Concepedia

Marion Adelfinger

MA

Statistics

Publications

8

Citations

275

H-Index

8

Active since

2010

Affiliations

University of Würzburg(Current)

Fleet Science Center

Genelux (United States)

University of California San Diego

University of Veterinary Medicine Hannover, Foundation

Marion Adelfinger is an author at University of Würzburg specializing in oncolytic virus therapy, oncology, and oncogenic viruses.

Publications per year

2010–2015

8

Publications

8

Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma

Ivaylo Gentschev, Marion Adelfinger, R Josupeit et al. · PLoS ONE · 2012 · 56 citations · Full text

, , +17

Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy

Marion Adelfinger, Simon Bessler, Alexa Frentzen et al. · Viruses · 2015 · 41 citations · Full text

, , +17

Regression of Human Prostate Tumors and Metastases in Nude Mice following Treatment with the Recombinant Oncolytic Vaccinia Virus GLV-1h68

Ivaylo Gentschev, Ulrike Donat, Elisabeth Hofmann et al. · Journal of Biomedicine and Biotechnology · 2010 · 39 citations · Full text

, , +16

Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68

Ivaylo Gentschev, Meike Müller, Marion Adelfinger et al. · PLoS ONE · 2011 · 39 citations · Full text

, , +17

Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody

Sandeep Patil, Ivaylo Gentschev, Marion Adelfinger et al. · PLoS ONE · 2012 · 34 citations · Full text

, , +17

1–5 of 8